NCT00408655View on ClinicalTrials.gov

Temsirolimus, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

January 31, 2012

Conditions
Ovarian SarcomaOvarian Stromal CancerRecurrent Endometrial CarcinomaRecurrent Ovarian Epithelial CancerRecurrent Ovarian Germ Cell TumorStage III Endometrial CarcinomaStage III Ovarian Epithelial CancerStage III Ovarian Germ Cell TumorStage IV Endometrial CarcinomaStage IV Ovarian Epithelial CancerStage IV Ovarian Germ Cell TumorUnspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

paclitaxel

Given IV

DRUG

carboplatin

Given IV

DRUG

temsirolimus

Given IV

Trial Locations (1)

K7L 3N6

National Cancer Institute of Canada Clinical Trials Group, Kingston

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00408655 - Temsirolimus, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid Tumors | Biotech Hunter | Biotech Hunter